High dose methylprednisolone in the management of acute spinal cord injury - A systematic review from a clinical perspective

Spinal Cord

Volumn 38, Issue 5, 2000, Pages 273-286

  Short, D J ^a   El Masry, W S ^a   Jones, P W ^b  

^a ROBERT JONES AND AGNES HUNT ORTHOPAEDIC HOSPITAL   (United Kingdom)

^b KEELE UNIVERSITY   (United Kingdom)

Author keywords

Dexamethasone; Methylprednisolone; SCI

Indexed keywords

DEXAMETHASONE; METHYLPREDNISOLONE; NALOXONE; NIMODIPINE; STEROID;

CANADA; CAT; CLINICAL TRIAL; HUMAN; MEDICAL EXAMINATION; MEDICAL INFORMATION; META ANALYSIS; MORBIDITY; MORTALITY; NEUROLOGY; NONHUMAN; OUTCOMES RESEARCH; PRIORITY JOURNAL; REVIEW; SPINAL CORD INJURY;

EID: 0034024692     PISSN: 13624393     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.sc.3100986     Document Type: Review

References (49)

1. 1 Bracken MB et al. A randomized controlled trial of Methylprednisolone or Naloxone in the treatment of acute spinal cord injury. New Engl J Med 1990; 322: 1405-1411.
2. 2 Altman DG. Practical Statistics for Medical Research. London: Chapman and Hall, 1991, p 466.
3. 3 Campbell MJ, Machin D. Medical Statistics: A Commonsense Approach (2nd edn). Chichester: J Wiley, 1993, pp 135-136.
4. 4 Bulpitt CJ. Subgroup analysis. Lancet 1988; 2: 31-34.
5. 5 Oxman AD, Guyatt GH. A consumer's guide to subgroup analyses. Ann Intern Med 1992; 116: 78-84.
6. 6 Woolf SH et al. Assessing the clinical effectiveness of preventive maneuvers: Analytic principles and systematic methods in reviewing evidence and developing clinical practice recommendations. J Clin Epidemiol 1990; 43: 891-905.
7. 7 Guyatt GH, Sackett DL, Cook DJ. Users' guides to the Medical Literature. JAMA 1993; 270: 2598-2601.
8. 8 Cook DJ, Guyatt GH, Laupacis A, Sackett DL. Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest 1992; 102: 305S-311S.
9. 9 Bracken MB. Pharmacology for spinal cord injury. Pharmacologic treatment of acute spinal cord injury. In: The Cochrane Library, Issue 4, 1998, Oxford: Update Software.
10. 10 Loblaw DA, Laperriere NJ. Emergency treatment of malignant extradural spinal cord. Compression: An evidence-based guideline. J Clin Oncol 1998; 16: 1613-1624.
11. 11 DeVivo MJ, Stover SL. Long-term survival and causes of death. In: Spinal Cord Injury: Clinical Outcomes from the Model Systems. Stover SL, DeLisa JA and Whiteneck GG (eds) Aspen Publishers, Inc: Gaithersburg, Maryland, 1995, pp 289-316.
12. 12 Bracken MB et al. Methylprednisolone and neurological function 1 year after spinal cord injury J Neurosurg 1985; 63: 704-713.
13. 13 Daverat P et al. Initial factors predicting survival in patients with a spinal cord injury. J Neurol, Neurosurg Psychiatry 1989; 52: 403-406.
14. 14 Pailthorpe CA. Trauma scores. In: Outcome Measures in Trauma. Pynsent PB, Fairbank JCT, Carr A (eds). Butterworth-Heinemann Ltd: Oxford, 1994, pp 1-16.
15. 15 Ditunno JF, Cohen ME, Formal C and Whiteneck GG. Functional Outcomes. In: Spinal Cord Injury. Clinical Outcomes from the Model Systems. Stover SL, DeLisa JA and Whiteneck GG (eds). Aspen Publishers Inc: Gaithersburg, Maryland, 1995, pp 170-183.
16. 16 Frankel HL et al. Value of postural reduction in the initial management of closed injuries of the spine with paraplegia and tetraplegia. Paraplegia 1969; 7: 179-192.
17. 17 Bracken MB et al. Methylprednisolone or naloxone treatment after acute spinal cord injury: 1 year follow up data. J Neurosurg 1992; 76: 23-31.
18. 18 Kiwerski J. The use of dexamethasone in the treatment of spinal cord early after injury. Neur Neurochair Pol 1992; 26: 518-527.
19. 19 Galandiuk S et al. The two-edged sword of large dose steroids for spinal cord trauma. Ann Surg 1993; 218: 419-427.
20. 20 Prendergast MR et al. Massive steroids do not reduce the zone of injury after penetrating spinal cord injury. J Trauma 1994; 37: 576-579.
21. 21 Gabler C, Maier R. Klinische Erfahrungen und Ergebnisse der hochdosierten Methylprednisolontherapie bei Rückenmarkstrauma von 1991 bis 1993. Unfallchirurgie 1995; 21: 20-29.
22. 22 Petitjean ME et al. Traitement médicamenteux de la lésion médllaire traumatique au stade aigu. Ann Fr Anesth Réanim 1998; 17: 114-122.
23. 23 Duh Mei-Sheng, Shepard MJ, Wilberger JE, Bracken MB. The effectiveness of surgery on the treatment of acute spinal cord injury and its relation to pharmacological treatment. Neurosurgery 1994; 35: 240-249.
24. 24 Otani K et al. Beneficial effect of methylprednisolone sodium succinate in the treatment of acute spinal cord injury. Sekitsui Sekizui J 1994; 7: 633-647.
25. 25 Poynton AR et al. An evaluation of the factors affecting neurological recovery following spinal cord injury. Injurv 1997; 28: 545-548.
26. 26 Gerhart KA et al. Utilization and effectiveness of methylprednisolone in a population-based sample of spinal cord injured persons. Paraplegia 1995; 33: 316-321.
27. 27 Gerndt SJ et al. Consequences of high-dose steroid therapy for acute spinal cord injury. J Trauma: Injury. Infect Crit Care 1997; 42: 279-282.
28. 28 George ER et al. Failure of methylprednisolone to improve the outcome of spinal cord injuries. Am Surg 1995; 61: 659-664.
29. 29 Heary RF. Steroids and gunshot wounds to the spine. Neurosurgery 1997; 41: 576-584.
30. 30 Levy ML et al. Use of methylprednisolone as an adjunct in the management of patients with penetrating spinal cord injury: Outcome analysis. Neurosurgery 1996; 39: 1141-1149.
31. 31 Green BA, Kahn T, Klose KJ. A comparative study of steroid therapy in acute experimental spinal cord injury. Surg Neurol 1980; 13: 91-97.
32. 32 Demopoulos HB et al. Further studies on free radical pathology in the major central nervous system disorders: effects of very high doses of methylprednisolone on the functional outcome, morphology and chemistry of experimental spinal cord impact injury. Can J Physiol Pharmacol 1982; 60: 1415-1424.
33. 33 Means ED, Anderson DK, Waters RT, Kalaf L. Effect of methylprednisolone in compression trauma to the feline spinal cord. J Neurosurg 1981; 55: 200-208.
34. 34 Anderson DK et al. Lipid hydrolysis and peroxidalion in injured spinal cord: partial protection with methylprednisolone or vitamin E and selenium. Centr Nerv Syst Trauma 1985; 2: 257-267.
35. 35 Braughler JM et al. Evaluation of an intensive methylprednisolone sodium succinate dosing regimen in experimental spinal cord injury. J Neurosurg 1987; 67: 102-105.
36. 36 Eidelberg E, Staten E, Watkins BS, Smith JS. Treatment of Experimental Spinal Cord Injury in Ferrets. Surg Neuro 1976; 6: 243-246.
37. 37 Hoerlein BF, Redding RW, Hoff EJ, McGuire JA. Evaluation of dexamethasone, DMSO, mannitol and solcoseryl in acute spinal cord trauma. J Am Animal Hosp Assoc 1983; 19: 216-226.
38. 38 Hoerlein BF, Redding RW, Hoff EJ, McGuire JA. Evaluation of naloxone, crocetin, TRH, methylprednisolone, partial myelotomy and hemilaminectomy in the treatment of acute spinal cord trauma. J Am Animal Hosp Assoc 1985; 21: 67-77.
39. 39 Faden AL, Jacobs TP, Holaday JW. Thyrotropin-releasing hormone improves neurological recovery after spinal trauma in cats. N Engl J Med 1981; 305: 1063-1067.
40. 40 Faden AI, Jacobs TP, Smith MT, Holaday JW. Comparison of thyrotropin-releasing hormone (TRH), naloxone and dexamethasone treatment in experimental spinal injuries. Neurology (Cleveland) 1983; 33: 673-678.
41. 41 Faden AI, Jacobs TP, Patrick DH, Smith MT. Megadose corticosteroid therapy following experimental traumatic spinal cord injury. J Neurosurg 1984; 60: 712-717.
42. 42 Coates JR et al. Clinicopathologic effects of a 21-aminosteroid compound (U74389G) and high-dose methylprednisolone on spinal cord function after simulated cord trauma. Veterinary Surgery 1995; 24; 128-139.
43. 43 Young W et al. Pharmacological therapy of acute spinal cord injury: studies of high dose methylprednisolone and naloxone. Clinical Neurosurgery 1988; 34, pp 675-697.
44. 44 Eidelberg E et al. A model of spinal cord injury. Surg Neuro 1976; 6: 35-38.
45. 45 Young W, Bracken MB. The second national acute spinal cord injury study. J Neurotrauma 1992; 9: S397-S405.
46. 46 Bracken MR, Holford TR. Effects of timing of methylprednisolone or naloxone administration on recovery of segmental and long tract Neurological function in NASCIS 2. J Neurosurg 1993; 79: 500-507.
47. 47 Altman DG. Better reporting of randomised controlled trials: the CONSORT statement. BMJ 1996; 313: 570-571.
48. 48 Begg C et al. Improving the quality of reporting of randomised controlled trials: the CONSORT statement. JAMA 1996; 276: 637-639.
49. 49 Walters EH, Walters JAE. Many reports of RCT's give insufficient data for Cochrane reviewers (letter). BMJ 1999; 319: 257.